Extendicare Inc. (TSE:EXE – Get Free Report) announced a monthly dividend on Friday, January 31st,TickerTech Dividends reports. Investors of record on Friday, February 14th will be given a dividend of 0.04 per share on Friday, February 14th. This represents a $0.48 dividend on an annualized basis and a yield of 4.63%. The ex-dividend date of this dividend is Friday, January 31st.
Extendicare Price Performance
TSE EXE opened at C$10.37 on Wednesday. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The stock’s fifty day moving average price is C$10.35 and its 200 day moving average price is C$9.16. The company has a market cap of C$865.58 million, a price-to-earnings ratio of 15.25 and a beta of 1.26. Extendicare has a 1 year low of C$6.63 and a 1 year high of C$10.89.
Extendicare (TSE:EXE – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share for the quarter. Extendicare had a net margin of 4.28% and a return on equity of 60.00%. During the same period in the prior year, the firm posted $0.13 EPS. As a group, equities research analysts forecast that Extendicare will post 0.6134729 earnings per share for the current year.
Wall Street Analyst Weigh In
Read Our Latest Research Report on Extendicare
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Most active stocks: Dollar volume vs share volume
- 3 Steel Stocks Soaring After Tariff Announcements
- Stock Average Calculator
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- What Are the FAANG Stocks and Are They Good Investments?
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.